Health Idea Now
Thursday, 29 March 2018
Pfizer's rare heart disease drug succeeds in late-stage study
(Reuters) - Pfizer Inc said on Thursday its drug tafamidis, for a rare and fatal disease associated with progressive heart failure, met the main goal in a late-stage study.
from Reuters: Health News https://ift.tt/2J5EhSX
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment